Chinese Innovation Breaks Into Europe: Reach Surgical's iReach Iris Powered Stapler Secures CE Mark
Genesis Medtech
Medical Device Research, Development, Production, and Sales
Medtronic
Medical Device Manufacturer
Johnson & Johnson
Medical Device R&D and Manufacturer
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
On April 15, 2026, Reach Surgical, the surgical solutions division of Genesis MedTech, announced that its next-generation powered surgical stapler platform, iReach Iris, has received CE Mark approval for market launch in the European Union.
In the powered stapler market, which has long been dominated by Medtronic (Signia) and Johnson & Johnson (ECHELON),Chinese brand Reach Surgical is making inroads in the European market with a combination of "real-time force feedback + wide joint movement + reusable" features.
I. Technical Core: The Force Feedback Revolution from "Blind Strike" to "Visible"
1.1 Data Dimension: Real-time firing curve makes the stapling process quantifiable and reviewable.
Traditional powered staplers provide doctors with feedback during firing, typically in the form of a single numerical value or a general "success/failure" indication. This "black-box" feedback means that doctors are unable to know the actual differences in tissue tension along the suture line, nor can they predict where Grade B or C leaks may occur.
iReach IrisReal-Time Firing Curve™This problem has been solved. The system continuously generates a continuous and position-specific force feedback curve during the firing process, mapping the entire suture line, which stands in stark contrast to traditional staplers that only offer general firing feedback. Through the curve, doctors can evaluate compression and firing irregularities associated with tissue variations, thereby identifying areas on the suture line that may require additional attention. The system also provides visual and auditory feedback during critical surgical steps, enhancing intraoperative awareness. The essence of this functionality is to upgrade the stapler from an "execution tool" to a "diagnostic tool." The firing curve serves not only as an operational record but also as a real-time assessment basis for tissue status.
Reach Surgical Working Principle Demonstration
1.2 Operating Dimension: 90° Wide Joint with Direction - Real Joint, Resolving Operational Bottlenecks in Complex Positions
In complex minimally invasive surgeries, whether the instrument can reach the target position is crucial to the success of the operation. The articulation range of traditional powered staplers is typically 45°-60°, which often falls short in anatomical locations such as the lower rectum, diaphragmatic angles, and deep pelvic regions.
iReach Iris ProvidedUp to 90° range of joint motion, far exceeding traditional levels. This capability not only allows the instrument to "turn" deeper but, more importantly, complementsOrientation-True ArticulationTechnology——The system directly translates the surgeon's intent into instrument movements, maintaining consistent articulation control even during jaw rotation. This means that doctors do not need to repeatedly adjust the instrument's orientation during complex procedures, significantly improving the smoothness of the surgery.
Figure 1. iReach Iris Product Image
1.3 Cost Dimension: Reusable handles reduce the cost per surgery, aligning with the European market's emphasis on sustainable healthcare.
Against the backdrop of disposable staplers dominating the mainstream market for a long time, iReach Iris has adopted“Reusable Handle + Disposable Staple Cartridge”A hybrid design. All patient-contacting components are for single-use, eliminating the need for re-sterilization, while the reusable handle and detachable power supply configuration reduce downtime required for charging. This design lowers the cost of consumables per surgery while ensuring safety, and reduces the generation of surgical waste, offering a clear competitive advantage in the European market, where sustainable healthcare is emphasized.
Figure 2.Reusable handle and detachable power supply
2. Market Landscape: The Intelligent Competition of Power Staplers
2.1 Track Overview: Billion-Dollar Market and the Wave of Intelligence
The global automatic surgical stapler market is expected to reach $5.88 billion by 2031, with a compound annual growth rate of approximately 4.0%. Powered staplers, as the fastest-growing subcategory, are undergoing a technological leap from "electrification" to "intelligence."
In the current market, major players have formed a clear differentiation in technical routes:
| Reach Surgical iReach Iris | Medtronic Signia™ | Johnson & Johnson ECHELON™ 3000 |
|---|---|---|
| 90° | 88° | |
| Real-time Firing Curve | Adaptive firing, automatically adjusts firing speed based on tissue thickness. | |
| Reusable | Reusable | |
Medtronic's Signia system is one of the most commercially mature products in the powered stapler field. Its core technologyAdaptive Firing™By measuring tissue thickness and density, the firing speed is automatically adjusted to ensure consistency of the suture line. The system is equipped with an OLED display that shows the status of the cartridge and firing readiness in real time, and features LED visual feedback functionality, providing instant alerts on the handle regarding cartridge status, clamping readiness, and error warnings.
The real-time firing curve of iReach Iris and the adaptive firing of Signia represent two different technical approaches. The former emphasizes "process visualization" – allowing doctors to see the force distribution along the entire suture line; the latter focuses on "automated optimization" – the system automatically adjusts firing parameters based on tissue characteristics.The two approaches have their own focuses, but in terms of transparency and traceability in clinical decision-making, the "curve" design of iReach Iris provides doctors with a more intuitive basis for judgment.
2.3 Johnson & Johnson ECHELON 3000: A Digital-Driven Entrant
ECHELON 3000, launched by Johnson & Johnson's Ethicon in 2022, is currently the closest competitor to the iReach Iris joint mobility capability. The product offers a joint movement range of up to 88° and is equipped with digital drive software that provides real-time auditory feedback. ECHELON 3000 enables one-handed operation through an integrated powered joint, offering surgeons a superior user experience.
In terms of joint range of motion, the iReach Iris has a slight advantage over the ECHELON 3000 with 90° compared to 88°, butReal-time Firing CurveThe core differentiating advantage of iReach Iris is its functionality.
3. Genesis MedTech: The Global Surgical Instrument Landscape Starting from the Chinese Market
3.1 Build a Surgical Product Matrix through Acquisition and Integration
Genesis MedTech (Jian Shi Medical) was founded in Singapore in 2019 as a multinational company dedicated to providing advanced medical devices to the global market. In the field of surgical instruments, Genesis has rapidly built a complete product portfolio through a series of strategic acquisitions and collaborations.
2019: Acquire Reach Surgical, a Chinese minimally invasive surgical instrument company established in 2005, focusing on endoscopic staplers and ultrasonic cutting and hemostasis systems.
Completion of Acquisition: Integrate Horcon (Nantong Huake, a Chinese suture company) to consolidate the suture supply chain.
Reach Cooperation: Obtained the exclusive distribution rights for Sejong Medical (Korea) trocar products in China.
Through this series of integrations, Genesis MedTech has built a complete product portfolio in the surgical field, covering staplers, ultrasonic scalpels, sutures, and trocars, with the capability to provide one-stop solutions for minimally invasive surgeries. The iReach Iris from Reach Surgical is a key outcome of this integration strategy.
3.2 From "Domestic Substitution" to "Global Competition"
Reach Surgical has already established a foundation for powered staplers in the Chinese market. Its iReach series has received NMPA approval in China and accumulated clinical usage experience domestically.The CE certification of iReach Iris marks the official entry of Genesis MedTech and Reach Surgical into Europe, the world's second-largest medical device market, where they will compete head-to-head with traditional giants like Medtronic and Johnson & Johnson.
Future Outlook and Industry Insights
Data-Driven Staplers: The Next Arena
The real-time firing curve of iReach Iris marks the evolution of the stapler from a "power tool" to a "data platform." When the stapler can record the force feedback curve of each suture line, this data can be used for postoperative review, doctor training, and quality control. In the long term, the intraoperative data generated by the stapler is expected to integrate with electronic medical record systems, becoming an objective basis for evaluating surgical quality.
Globalization Window for Chinese Brands
iReach Iris Obtains CE Certification Amid Cost Pressures Facing European Healthcare Systems. In the European market, dominated by traditional giants such as Medtronic and Johnson & Johnson, Chinese brands have a clear competitive edge by entering with "technological differentiation + cost advantage." The global supply chain and registration capabilities built through acquisitions and integration by Genesis MedTech have provided Reach Surgical with a fast track to enter the European market.
The Reusable Environmental Value
In Europe, the cost of medical waste disposal is rising. The extensive use of disposable staplers generates significant plastic and metal waste. The reusable handle design of iReach Iris reduces the consumption of disposable plastics while meeting clinical needs, an environmentally friendly feature that will become increasingly important in purchasing decisions within the European market.
? Click to view more exciting content
$585 Million Acquisition of CathWorks: Medtronic Gains AI-FFR Coronary Product Portfolio